What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling.

Evison, Matthew; Maconachie, Ross; Mercer, Toby; Daly, Caitlin H; Welton, Nicky J; Aslam, Shahzeena; West, Doug; Navani, Neal.

Afiliação

Evison M; Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Maconachie R; NICE Centre for Guidelines, National Institute for Health and Care Excellence, Manchester, UK.
Mercer T; NICE Centre for Guidelines, National Institute for Health and Care Excellence, Manchester, UK.
Daly CH; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Welton NJ; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Aslam S; Bedford and Addenbrooke's Cambridge University NHS Hospital Trusts, Cambridge, UK.
West D; Department of Thoracic Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Navani N; Department of Respiratory Medicine, University College London Hospital, London, UK.

ERJ Open Res ; 9(2)2023 Mar.

Article em En | MEDLINE | ID: mdl-37020838

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article